SOTHEMACAS:SOT +1.05%71 Forward Dividend Yield % is 1.74% as of Jun. 26, 2026. GuruFocus rates CAS:SOT with a GF Score™ of 71/100 and a GF Value™ of MAD284.90 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 504 Drug Manufacturers companies, SOTHEMA ranks worse than 55.95% on this metric.
As of today (2026-06-26), the Forward Annual Dividend Yield of SOTHEMA is 1.74%.
As of today (2026-06-26), the Trailing Annual Dividend Yield of SOTHEMA is 1.47%.
CAS:SOT's Forward Dividend Yield % is ranked worse than 55.95% of 504
companies
in the Drug Manufacturers industry
Industry Median: 2.08
vs CAS:SOT: 1.74
During the past 12 months, SOTHEMA's average Dividends Per Share Growth Rate was 64.70% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 3.80% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 5.70% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was 9.20% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of SOTHEMA was 41.90% per year. The lowest was -6.80% per year. And the median was 10.95% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
CAS:SOT vs LLY, JNJ, ABBV: Forward Dividend Yield % Comparison
For the Drug Manufacturers - General subindustry, SOTHEMA's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SOTHEMA Forward Dividend Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, SOTHEMA's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where SOTHEMA's Forward Dividend Yield % falls into.
What does a Forward Dividend Yield % of 1.74% mean?
SOTHEMA (CAS:SOT) has a Forward Dividend Yield % of 1.74% as of Jun. 26, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on SOTHEMA and its competitors. According to the industry distribution chart, SOTHEMA ranks #282 out of 504 companies in the Drug Manufacturers industry, placing it in the top 56%.
Is SOTHEMA's Forward Dividend Yield % too high?
SOTHEMA's current Forward Dividend Yield % is 1.74%. The Drug Manufacturers industry median Forward Dividend Yield % is 2.08. SOTHEMA's value of 1.74% is 16.3% below this industry median. Based on the distribution chart, SOTHEMA ranks #282 out of 504 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, SOTHEMA has a GF Score™ of 71/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does SOTHEMA's Forward Dividend Yield % compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, SOTHEMA ranks #282 out of 504 companies for Forward Dividend Yield %. This places SOTHEMA in the lower half of its industry. The industry median Forward Dividend Yield % is 2.08. SOTHEMA's value of 1.74% is 16.3% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Drug Manufacturers company?
The median Forward Dividend Yield % among Drug Manufacturers companies is 2.08, based on 504 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SOTHEMA's current Forward Dividend Yield % of 1.74% is 16.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on SOTHEMA and its competitors. For the Drug Manufacturers industry, the median Forward Dividend Yield % is 2.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SOTHEMA's current Forward Dividend Yield % is 1.74%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SOTHEMA stock overvalued right now?
Based on GuruFocus' analysis, SOTHEMA (CAS:SOT) is currently considered Significantly Overvalued. The stock's GF Value™ is MAD284.90, compared to a current price of MAD379.95 — trading 33.4% above its estimated fair value. The current Forward Dividend Yield % is 1.74% and 16.3% below the Drug Manufacturers industry median of 2.08. SOTHEMA's overall GF Score™ is 71/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For SOTHEMA (CAS:SOT), the current Forward Dividend Yield % is 1.74% as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SOTHEMA (CAS:SOT) Overvalued in 2026?
Based on GuruFocus' analysis, SOTHEMA stock appears to be overvalued.
The current stock price of MAD379.95 is trading 33.4% above its estimated GF Value™ of MAD284.90.
GuruFocus considers SOTHEMA to be Significantly Overvalued.
Key valuation signals for CAS:SOT:
Forward Dividend Yield %: 1.74%
GF Value™: MAD284.90 vs. price of MAD379.95 (33.4% above fair value)
Industry Position: 16.3% below the Drug Manufacturers median (#282 of 504)
No single metric tells the full story. See the CAS:SOT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SOTHEMA engages in representation, purchase and sale of pharmaceutical, chemical, health-related, biological, veterinary, plant-based, cosmetic and scented products. The company sells its products in Morocco and overseas.
71GF Score
Get the complete analysis for CAS:SOT
Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CAS:SOT has been successfully added to your 